The ports of military in myanmar code was draw out the results of november pause my collection. And how all these lockdown video calls from home have prompted an unexpected book the macro boost in business for books. Welcome, youre in bbc news. The European Union has announced its introducing Export Controls on Coronavirus Vaccines so that it can monitor where theyre being sent. Its the latest escalation in a deepening row between the eu and astrazeneca over supplies of the vaccine which is mostly produced here. Today the eus Medicines Regulator approved the use of the astrazeneca jab for everyone over the age of 18, though germany says it will still only give the jab to the under 65s. Our brussels correspondent nick beake reports. Throughout the week, this post brexit battle between the eu and a british based Vaccine Maker has been intensifying. European countries are demanding that astrazeneca delivers all the jabs they ordered even if it means taking them from the uk supply. It all hangs on the contract the two sides signed, thats now been released, with parts blanked out. Astrazeneca says it agreed to do its reasonable best. The eu insists it was a legally binding promise. And so, its now announced, if it doesnt get what it ordered, it could block Covid Vaccines leaving europe, heading for some countries, including the uk. We have to be very clear and we have said it many times before. We are not protecting ourselves against any specific country, and we are not in competition or in a race against any country. The only race we are in is against this virus. At pfizers vaccine making hq in northern belgium, security is tight. Few commodities more precious at the moment than covid jabs. Thats why theyre carefully escorted on their way. Its not clear cut supplies to the uk will be affected by these new eu restrictions. The European Union is taking a really tough line in this covid row. But at the same time, its facing heavy criticism for the slowness of its vaccination roll out its much slower than the uks. Throughout this pandemic, brussels has insisted all 27 countries need to Work Together when it comes to getting hold of jabs. So far, its not worked well. Because this is a rare sight in cities like madrid. Thousands of other Vaccine Appointments have had to be postponed. Today, though, some hope with europes medicine regulator finally approving the astrazeneca vaccine at the heart of this weeks dispute. Downing street is desperate to stay out of the eu astrazeneca row, but insists uk Vaccine Supplies would not be affected. Im not going to comment on the eus own discussions with those manufacturers. What we need to focus on making sure that uk residents and the nhs here gets the vaccines thats required, and were confident that we will be receiving what we expected in the days and weeks ahead. But one senior eu official accused borisjohnson� s government of wanting to start a vaccine war. Resolving this row is not going to be easy. Nick beake, bbc news, brussels. The chief executive officer of astrazeneca, pascal soriot, says the company is working hard to make sure the eu gets all the doses it needs. Weve been working 24 7 to import the supply that we have. To start with, we have millions of doses that we are ready to start shipping to the eu over the next few days and weeks. So, you know, we have quite a a substantial quantity already to the ship to the various countries. And we are working 20 47 to increase this capacity. 24 7. Weve identified any additional sources of what we call dry substance that we are redeploying from all parts of the world so we can top up the supply that we have in europe and make sure that we vaccinate as many people as possible in europe very quickly. Thats the ceo of astrazeneca. Breaking news that came to us a short while ago, this has to do with Northern Ireland, where the First Minister has accused the eu of an incredible act of hostility over its decision to override part of the brexit treaty when it comes to Vaccine Exports. The eu has invoked a particular article of the treaty called article 16 in order to prevent a so back door supply chain of vaccines from europe reaching the water uk across the irish border. Arlene foster said it was prepared just the eu was prepared to use Northern Ireland when it served their interests in a despicable manner and the shipping of a vaccine which is decide the micro design test save lives. The government and the First Minister says it is considering its options. Breaking news having to do with that Vaccine Export thats been introduced by the eu, more on that to come. Yet another new vaccine has been shown to be effective in major trials in just 2a hours. The latest is the janssen vaccine. Its 66 effective overall and only needs a single dose. And crucially its 85 effective against severe disease. Last night, novavax announced uk trials had shown its vaccine to be 89 effective. And crucially that vaccine protects against the new more contagious uk variant. If approved, the uk has millions of doses of both vaccines on order. Though they wouldnt be available until later in the year. Our medical editor fegus walsh reports Covid Vaccine trials keep delivering results beyond all expectations. These volunteers in southampton are among Tens Of Thousands worldwide testing the vaccine from janssen part of the pharmaceutical giantjohnson johnson. We have a single shot vaccine which can protect very highly 85 against severe disease, and complete protection against death and hospitalisation after day 28. And thats a finding which was across the world in all the regions, independent of age and strain. The results from the us Biotech Novavax are nothing short of spectacular. This site in london, part of the uk wide trial, which showed the vaccine offered strong protection even against the contagious new variant first identified in kent. Its very significant because we were able to show that the vaccine works well against both the old, the original strain and the new strain. It had 96 efficacy against the original covid 19 strain. And yet it still had 86 efficacy against the variant strain. So how do they work . The novavax jab uses proteins from the Surface Spike of coronavirus and combines these with a chemical booster, or agile end. The janssen vaccine puts the gene for the spike protein into a harmless virus a similar approach to the Oxford Astrazeneca job. Both vaccines prime the immune system, including creating antibodies which will target coronavirus in the event of infection. The novavax jab will be manufactured on teesside, part of the deal struck last year to ensure a steady flow of vaccine. The uk has ordered 100 million doses of the Oxford Astrazeneca vaccine and a0 million of pfizers both of these are in limited supply at the moment. The 17 million doses of modernas vaccine wont arrive until the spring. Then theres the two vaccines which just yielded results. 60 million doses of the novavax jab will take a few months to be delivered, Plus 30 Million of the single dose janssen vaccine. Now if those last two are approved, thatll be enough doses to immunise the entire Uk Population twice over. Two more vaccines to add to the toolbox gives more resilience and more tools, new tools that were different than the last ones. And it means we can spread the vaccine around, it means we can really start to impact on this pandemic notjust here, but right away across the world. You ready . Yes. Vaccinating one country in a pandemic is like putting a sticking plaster on a gaping wound. Until the whole world is protected, none of us truly will be. Fergus walsh, bbc news. The Belgian Company janssen says its single dose Coronavirus Vaccine is 66 effective. Saul faust is a professor of Paediatric Immunology and Infectious Diseases at the university of southampton. He is running janssen� s Clinical Trial in the uk. Good to speak to you. First of all, getting this Efficacy Rate must be a big boost for you and your team . Its an amazing result because to be able to use a single dose of vaccine that can be transported at Room Temperature is a global game changer, not to have to bring people back for a second dose. As my colleague just back for a second dose. As my colleaguejust said on back for a second dose. As my colleague just said on your piece, its another two vaccines in the last day to add to the armoury. The janssen one has very high efficacy against the severe disease, but the really spectacular part of this is that its 100 really spectacular part of this is that its100 effective, apparently, and stopping people going into hospital or dying regardless of the location or age, or the geography. So this study was donein or the geography. So this study was done in south africa, and america and latin america. But people of all ages, overthe and latin america. But people of all ages, over the age of 60, and including the mutated virus in south africa as quite a big part of it. And the lack of being in hospital or death in the single dose groups are really amazing. In the uk, we are doing the two dose study, and that will be important to know how to use the vaccine in future. Ill will be important to know how to use the vaccine in future. The vaccine in future. Ill go back to that in a the vaccine in future. Ill go back to that in a moment, the vaccine in future. Ill go back to that in a moment, but the vaccine in future. Ill go back to that in a moment, but going i the vaccine in future. Ill go back to that in a moment, but going back to that in a moment, but going back to the Efficacy Data we have, the sample of people involved in the trial gives us an indication of what were talking about here in terms of the actual experiment. I want to talk to you about the 66 weve been talking about thats been hitting the headlines, because although you say its 100 the headlines, because although you say its100 effective in preventing hospitalisation, we still understand it to be 66 effective. So talk me through that. So understand it to be 66 effective. So talk me through that. Understand it to be 66 effective. So talk me through that. So what i think peeple so talk me through that. So what i think people need so talk me through that. So what i think people need to so talk me through that. So what i think people need to understand l so talk me through that. So what i | think people need to understand is that these figures bandied about are really hard to compare child for trial. Its like comparing apples and oranges to pears. Trial to trial. It comes from people in detected studies who have had a proven swab. Similar with the Astrazeneca Oxford study in the uk, there was a very low threshold for bringing people into have a swab. So at the bit like when we look at the flu vaccines and their 70 80 effectiveness. They are actually quite good at stopping people getting ill, and thats the point about these vaccines. Getting ill, and thats the point about these vaccines. Getting ill, and thats the point about these vaccines. What do you mean about about these vaccines. What do you mean about a about these vaccines. What do you mean about a low about these vaccines. What do you mean about a low threshold, about these vaccines. What do you mean about a low threshold, if about these vaccines. What do you mean about a low threshold, if i about these vaccines. What do you mean about a low threshold, if i can | mean about a low threshold, if i can interrupt . So mean about a low threshold, if i can interru t . ~ mean about a low threshold, if i can interrut . ~. , interrupt . So the who said at the beauinnin , interrupt . So the who said at the beginning, before interrupt . So the who said at the beginning, before we interrupt . So the who said at the beginning, before we had interrupt . So the who said at the beginning, before we had any beginning, before we had any vaccines, we wouldve accepted 50 . We are talking 70 90 now. And remember, these figures are based on the first month or two months after the first month or two months after the vaccine is at its most effective. So if you look for the disease in people with mild symptoms, the percentage that you find and whether its effective is less if you define severe disease as fever and bad cough. Even more severe disease is getting in hospital and dying. So we have to take a step back and say that all these vaccines being approved are really good at stopping people dying and going into hospital. And thats the first thing we need to do with the first thing we need to do with the pandemic, to ease the pressure on health system. On health system. Forgive me for interrunting. On health system. Forgive me for interrupting, because on health system. Forgive me for interrupting, because im on health system. Forgive me for l interrupting, because im conscious of the time weve got and theres so many questions, but with that in mind, youre saying that with a single dose, this could be as effective as it can . You just said that youre looking into the potential of a second dose or initial trials on that. Are you saying that a single dose is enough . We will find out. The nhra and other regulators Around The World will decide whether a single dose can be used. But thats what it looks like. The two dose study we are studying in the uk is important because it could be that the second dose will provide even higher and longer protection. And we know that because for many vaccines and diseases, prospectuses is better than one. The first stage just primes the Immune Systems two doses. And the booster dose can provide even more protection and memory response over a long period of time. And protection and memory response over a long period of time. A long period of time. And is there a long period of time. And is there a timeframe a long period of time. And is there a timeframe between a long period of time. And is there a timeframe between the a long period of time. And is there a timeframe between the two . A long period of time. And is there a timeframe between the two . So | a long period of time. And is there a timeframe between the two . So the janssen a timeframe between the two . So the janssen study a timeframe between the two . So the janssen study is a timeframe between the two . So the janssen study is testing a timeframe between the two . So the janssen study is testing two a timeframe between the two . So the janssen study is testing two months. L janssen study is testing two months. And as we know, the Oxford Astrazeneca vaccine is better when its delayed to around three months. So its a very common phenomenon in vaccines that an extra delay is better. The Vaccine Trials are done because somebody decides theyll test 3 5 weeks, but normally longer is better. Test 35 weeks, but normally longer is better. ~ �. ,. , is better. Weve run out of time, ust in a is better. Weve run out of time, just in a yes is better. Weve run out of time, just in a yes or is better. Weve run out of time, just in a yes or no is better. Weve run out of time, just in a yes or no if is better. Weve run out of time, just in a yes or no if you is better. Weve run out of time, just in a yes or no if you can, is better. Weve run out of time, | just in a yes or no if you can, will we be needing these vaccines annually . We we be needing these vaccines annually . We be needing these vaccines annuall 7~. , � ~. , , annually . We dont know yet but we miaht annually . We dont know yet but we might well. Annually . We dont know yet but we might well, thats annually . We dont know yet but we might well, thats why annually . We dont know yet but we might well, thats why we annually . We dont know yet but we might well, thats why we need annually . We dont know yet but we might well, thats why we need to i might well, thats why we need to know about the further doses. Thank ou so know about the further doses. Thank you so much know about the further doses. Thank you so much for know about the further doses. Thank you so much forjoining know about the further doses. Thank you so much forjoining us know about the further doses. Thank you so much forjoining us in you so much forjoining us in sharing your thoughts with us. Thank ou. Sharing your thoughts with us. Thank you incredibly sharing your thoughts with us. Thank you. Incredibly busy sharing your thoughts with us. Thank you. Incredibly busy day, sharing your thoughts with us. Thank you. Incredibly busy day, were sharing your thoughts with us. Thank you. Incredibly busy day, were going | you. Incredibly busy day, were going to rattle through you. Incredibly busy day, were going to rattle through this you. Incredibly busy day, were going to rattle through this because you. Incredibly busy day, were going to rattle through this because we to rattle through this because we have lots to talk about. As weve heard, 60 million doses of the Novavax Vaccine will be made on teesside. Rachel anderson is Assistant Director of policy at the North East England Chamber of commerce. Thank you so much forjoining us. A huge boost to the region, how are you feeling . Its huge boost to the region, how are you feeling . Huge boost to the region, how are ou feelin . � ,. ,. ,. , you feeling . Its a tremendous vote of confidence you feeling . Its a tremendous vote of confidence in you feeling . Its a tremendous vote of confidence in our you feeling . Its a tremendous vote of confidence in our sector, you feeling . Its a tremendous vote of confidence in our sector, and of confidence in our sector, and weve G